Temporal expression of proteoglycans in the rat limb during bone healing.
暂无分享,去创建一个
D. Hutmacher | V. Nurcombe | S. Cool | S M Cool | V Nurcombe | S J Song | D Hutmacher | S. Song | S. Song | D. W. Hutmacher | Shu Jun Song
[1] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[2] P. Marie,et al. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. , 1999, Bone.
[3] Yoshihiko Yamada,et al. Role of perlecan in skeletal development and diseases , 2002, Glycoconjugate Journal.
[4] B. Barlogie,et al. Syndecan-1 is a multifunctional regulator of myeloma pathobiology: control of tumor cell survival, growth, and bone cell differentiation. , 1998, Blood.
[5] H. Ozawa,et al. Immunohistochemical localization of heparan sulfate proteoglycan in rat tibiae , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] M. Detmar,et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. , 2001, The Journal of clinical investigation.
[7] R. Timpl,et al. Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes , 1999, The Journal of cell biology.
[8] D. Ornitz,et al. FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] M. Goldfarb,et al. Heparin can activate a receptor tyrosine kinase. , 1995, EMBO Journal.
[10] W. Young,et al. Differential expression and distribution of syndecan-1 and -2 in periodontal wound healing of the rat. , 2002, Journal of periodontal research.
[11] K. Fukada,et al. In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage , 2003, Journal of anatomy.
[12] S. Selleck. Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. , 2000, Trends in genetics : TIG.
[13] E. Ogata,et al. Effects of transforming growth factor β1 and l‐ascorbate on synthesis and distribution of proteoglycans in murine osteoblast‐like cells , 1993 .
[14] G. Carpentier,et al. Heparan-like molecules induce the repair of skull defects. , 1995, Bone.
[15] J. Heath,et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. , 1997, Development.
[16] T Matsumoto,et al. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.
[17] E. Vuorio,et al. A standardized experimental fracture in the mouse tibia , 1993, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[18] E. Canalis,et al. Skeletal growth factors. , 2000, Critical reviews in eukaryotic gene expression.
[19] D. Lane,et al. Heparin and Related Polysaccharides , 1992, Advances in Experimental Medicine and Biology.
[20] T. Einhorn,et al. Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat. , 2001, Bone.
[21] I. Takahashi,et al. Expression of Versican and ADAMTS1, 4, and 5 During Bone Development in the Rat Mandible and Hind Limb , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[22] E. Mackie,et al. Establishment of a Model of Cortical Bone Repair in Mice , 2003, Calcified Tissue International.
[23] A. Lander,et al. Expression of the heparan sulfate proteoglycan glypican‐1 in the developing rodent , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.
[24] J O Hollinger,et al. The critical size defect as an experimental model for craniomandibulofacial nonunions. , 1986, Clinical orthopaedics and related research.
[25] J. Hecht,et al. Expression of the Heparan Sulfate Proteoglycan, Perlecan, during Mouse Embryogenesis and Perlecan Chondrogenic Activity In Vitro , 1999, The Journal of cell biology.
[26] T. Einhorn,et al. Spatial and temporal distribution of CD44 and osteopontin in fracture callus. , 1999, The Journal of bone and joint surgery. British volume.
[27] R. Midura,et al. Plasma-membrane-intercalated heparan sulphate proteoglycans in an osteogenic cell line (UMR 106-01 BSP). , 1992, Biochemical Journal.
[28] M. Young,et al. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.
[29] J. Heath,et al. Functions of fibroblast growth factors and their receptors , 1995, Current Biology.
[30] E. Ruoslahti,et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.
[31] P. Leder,et al. Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.
[32] G. Karsenty,et al. Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.
[33] M. Klagsbrun,et al. A dual receptor system is required for basic fibroblast growth factor activity , 1991, Cell.
[34] L. Gold,et al. New concepts in tissue repair: skin as an example. , 1996, Diabetes & metabolism.
[35] T A Einhorn,et al. Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] Mark E. Bolander,et al. Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[37] G. David,et al. Structural and functional diversity of the heparan sulfate proteoglycans. , 1992, Advances in experimental medicine and biology.
[38] L. Sandell,et al. Extracellular matrix gene regulation. , 2004, Clinical orthopaedics and related research.
[39] Yoshihiko Yamada,et al. Perlecan is essential for cartilage and cephalic development , 1999, Nature Genetics.
[40] J B Lian,et al. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. , 1989, Physiological reviews.
[41] W. Hornebeck,et al. FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. , 1996, International Journal of Biological Macromolecules.
[42] C. Stuelten,et al. Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells* , 2005, Journal of Biological Chemistry.
[43] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[44] Arnold Munnich,et al. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.
[45] E. Canalis,et al. Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.
[46] G. Karsenty,et al. Osteocalcin cluster: Implications for functional studies , 1995, Journal of cellular biochemistry.
[47] D. Gospodarowicz,et al. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. , 1989, Endocrinology.
[48] S A Goldstein,et al. Aggrecan core protein is expressed in membranous bone of the chick embryo. Molecular and biomechanical studies of normal and nanomelia embryos. , 1992, The Journal of biological chemistry.
[49] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[50] E. Jabs,et al. Mutations in fibroblast growth factor receptors: phenotypic consequences during eukaryotic development. , 1995, American journal of human genetics.
[51] E. Ogata,et al. Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process. , 1990, The Biochemical journal.
[52] W. Knudson,et al. Cartilage proteoglycans. , 2001, Seminars in cell & developmental biology.
[53] M. Young,et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[54] E. Ruoslahti. Proteoglycans in cell regulation. , 1989, Journal of Biological Chemistry.
[55] Kozo Nakamura,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Acceleration of Fracture Healing in Nonhuman Primates by Fibroblast Growth Factor-2 , 2022 .
[56] W. Wilcox,et al. Dyssegmental dysplasia, Silverman-Handmaker type: Unexpected role of perlecan in cartilage development# , 2001 .
[57] H. Kleinman,et al. Proteoglycans of developing bone. , 1983, The Journal of biological chemistry.
[58] Benjamin M. Wu,et al. Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. , 2005, Tissue engineering.
[59] R. Gamelli,et al. Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation. , 1999, The Biochemical journal.
[60] Erkki Ruoslahti,et al. Proteoglycans as modulators of growth factor activities , 1991, Cell.
[61] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[62] M. Stepp,et al. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse , 2002, Journal of Cell Science.